Financial reports
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
1 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
11 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
29 Aug 23
8-K
Tender and Support Agreement
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
8-K
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results
15 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 May 23
8-K
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
28 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Other Events
9 Jan 23
8-K
Zynerba Pharmaceuticals Announces Update on RECONNECT, the Pivotal Phase 3 Trial of Zygelâ„¢ in Fragile X Syndrome
21 Dec 22
Registration and prospectus
15-12G
Securities registration termination
19 Oct 23
POS AM
Prospectus update (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Oct 23
Proxies
DEFA14A
Additional proxy soliciting materials
8 Aug 23
DEFA14A
Additional proxy soliciting materials
25 Jul 23
DEFA14A
Additional proxy soliciting materials
28 Jun 23
DEFA14A
Additional proxy soliciting materials
13 Jun 23
DEFA14A
Additional proxy soliciting materials
6 Jun 23
DEFA14A
Additional proxy soliciting materials
15 May 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
DEFA14A
Additional proxy soliciting materials
25 Apr 22
Other
EFFECT
Notice of effectiveness
12 Oct 23
CORRESP
Correspondence with SEC
14 Sep 23
UPLOAD
Letter from SEC
7 Sep 23
UPLOAD
Letter from SEC
7 Sep 23
EFFECT
Notice of effectiveness
13 Jun 22
CORRESP
Correspondence with SEC
8 Jun 22
UPLOAD
Letter from SEC
24 May 22
EFFECT
Notice of effectiveness
14 Aug 19
CORRESP
Correspondence with SEC
9 Aug 19
UPLOAD
Letter from SEC
8 Aug 19
Ownership
SC 13G/A
Beryl Capital Management LLC
8 Feb 24
4
Kenneth T Jones
11 Oct 23
4
Pamela Stephenson
11 Oct 23
4
James E Fickenscher
11 Oct 23
4
Terri B Sebree
11 Oct 23
4
WILLIAM J FEDERICI
11 Oct 23
4
Brian Rosenberger
11 Oct 23
4
WARREN D COOPER
11 Oct 23
4
Albert P Parker
11 Oct 23
4
John P. Butler
11 Oct 23